Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To demonstrate the non-inferiority of CHF1535 100/6 μg NEXThaler® versus CHF1535 100/6 μg pMDI on the onset of relief from methacholine-induced bronchospasm, in terms of pulmonary function [change in FEV1 (L) from baseline, i.e. post-diluent, to 5 min after study drug inhalation] in asthmatic patients on low-medium doses of ICS or ICS plus LABA fixed or free combination.
Critère d'inclusion
- Asthma